Cargando…

Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis

BACKGROUND: One of the challenges facing the tuberculosis (TB) control programmes in resource-limited settings is lack of rapid techniques for detection of drug resistant TB, particularly multi drug resistant tuberculosis (MDR TB). Results obtained with the conventional indirect susceptibility testi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bwanga, Freddie, Hoffner, Sven, Haile, Melles, Joloba, Moses L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696456/
https://www.ncbi.nlm.nih.gov/pubmed/19457256
http://dx.doi.org/10.1186/1471-2334-9-67
_version_ 1782168269244858368
author Bwanga, Freddie
Hoffner, Sven
Haile, Melles
Joloba, Moses L
author_facet Bwanga, Freddie
Hoffner, Sven
Haile, Melles
Joloba, Moses L
author_sort Bwanga, Freddie
collection PubMed
description BACKGROUND: One of the challenges facing the tuberculosis (TB) control programmes in resource-limited settings is lack of rapid techniques for detection of drug resistant TB, particularly multi drug resistant tuberculosis (MDR TB). Results obtained with the conventional indirect susceptibility testing methods come too late to influence a timely decision on patient management. More rapid tests directly applied on sputum samples are needed. This study compared the sensitivity, specificity and time to results of four direct drug susceptibility testing tests with the conventional indirect testing for detection of resistance to rifampicin and isoniazid in M. tuberculosis. The four direct tests included two in-house phenotypic assays – Nitrate Reductase Assay (NRA) and Microscopic Observation Drug Susceptibility (MODS), and two commercially available tests – Genotype(® )MTBDR and Genotype(® )MTBDRplus (Hain Life Sciences, Nehren, Germany). METHODS: A literature review and meta-analysis of study reports was performed. The Meta-Disc software was used to analyse the reports and tests for sensitivity, specificity, and area under the summary receiver operating characteristic (sROC) curves. Heterogeneity in accuracy estimates was tested with the Spearman correlation coefficient and Chi-square. RESULTS: Eighteen direct DST reports were analysed: NRA – 4, MODS- 6, Genotype MTBDR(® )– 3 and Genotype(® )MTBDRplus – 5. The pooled sensitivity and specificity for detection of resistance to rifampicin were 99% and 100% with NRA, 96% and 96% with MODS, 99% and 98% with Genotype(® )MTBDR, and 99% and 99% with the new Genotype(® )MTBDRplus, respectively. For isoniazid it was 94% and 100% for NRA, 92% and 96% for MODS, 71% and 100% for Genotype(® )MTBDR, and 96% and 100% with the Genotype(® )MTBDRplus, respectively. The area under the summary receiver operating characteristic (sROC) curves was in ranges of 0.98 to 1.00 for all the four tests. Molecular tests were completed in 1 – 2 days and also the phenotypic assays were much more rapid than conventional testing. CONCLUSION: Direct testing of rifampicin and isoniazid resistance in M. tuberculosis was found to be highly sensitive and specific, and allows prompt detection of MDR TB.
format Text
id pubmed-2696456
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26964562009-06-16 Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis Bwanga, Freddie Hoffner, Sven Haile, Melles Joloba, Moses L BMC Infect Dis Research Article BACKGROUND: One of the challenges facing the tuberculosis (TB) control programmes in resource-limited settings is lack of rapid techniques for detection of drug resistant TB, particularly multi drug resistant tuberculosis (MDR TB). Results obtained with the conventional indirect susceptibility testing methods come too late to influence a timely decision on patient management. More rapid tests directly applied on sputum samples are needed. This study compared the sensitivity, specificity and time to results of four direct drug susceptibility testing tests with the conventional indirect testing for detection of resistance to rifampicin and isoniazid in M. tuberculosis. The four direct tests included two in-house phenotypic assays – Nitrate Reductase Assay (NRA) and Microscopic Observation Drug Susceptibility (MODS), and two commercially available tests – Genotype(® )MTBDR and Genotype(® )MTBDRplus (Hain Life Sciences, Nehren, Germany). METHODS: A literature review and meta-analysis of study reports was performed. The Meta-Disc software was used to analyse the reports and tests for sensitivity, specificity, and area under the summary receiver operating characteristic (sROC) curves. Heterogeneity in accuracy estimates was tested with the Spearman correlation coefficient and Chi-square. RESULTS: Eighteen direct DST reports were analysed: NRA – 4, MODS- 6, Genotype MTBDR(® )– 3 and Genotype(® )MTBDRplus – 5. The pooled sensitivity and specificity for detection of resistance to rifampicin were 99% and 100% with NRA, 96% and 96% with MODS, 99% and 98% with Genotype(® )MTBDR, and 99% and 99% with the new Genotype(® )MTBDRplus, respectively. For isoniazid it was 94% and 100% for NRA, 92% and 96% for MODS, 71% and 100% for Genotype(® )MTBDR, and 96% and 100% with the Genotype(® )MTBDRplus, respectively. The area under the summary receiver operating characteristic (sROC) curves was in ranges of 0.98 to 1.00 for all the four tests. Molecular tests were completed in 1 – 2 days and also the phenotypic assays were much more rapid than conventional testing. CONCLUSION: Direct testing of rifampicin and isoniazid resistance in M. tuberculosis was found to be highly sensitive and specific, and allows prompt detection of MDR TB. BioMed Central 2009-05-20 /pmc/articles/PMC2696456/ /pubmed/19457256 http://dx.doi.org/10.1186/1471-2334-9-67 Text en Copyright ©2009 Bwanga et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bwanga, Freddie
Hoffner, Sven
Haile, Melles
Joloba, Moses L
Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
title Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
title_full Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
title_fullStr Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
title_full_unstemmed Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
title_short Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
title_sort direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696456/
https://www.ncbi.nlm.nih.gov/pubmed/19457256
http://dx.doi.org/10.1186/1471-2334-9-67
work_keys_str_mv AT bwangafreddie directsusceptibilitytestingformultidrugresistanttuberculosisametaanalysis
AT hoffnersven directsusceptibilitytestingformultidrugresistanttuberculosisametaanalysis
AT hailemelles directsusceptibilitytestingformultidrugresistanttuberculosisametaanalysis
AT jolobamosesl directsusceptibilitytestingformultidrugresistanttuberculosisametaanalysis